Stojanovic-Susulic; Vedrana

Patent Applications and Registrations

Patent applications and USPTO patent grants for Stojanovic-Susulic; Vedrana.The latest application filed is for "anti-il-6 antibody".

Company Profile

1.19.28

Stojanovic-Susulic; Vedrana - Princeton Junction NJ
Stojanovic-Susulic; Vedrana - Spring House PA
Stojanovic-Susulic; Vedrana - Radnor PA US
Stojanovic-Susulic; Vedrana - Malvern PA
Stojanovic-Susulic; Vedrana - Princeton NJ

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Anti-IL-6 Antibody App 20220048985 - Chen; Yan ; et al.	2022-02-17
Methods of suppressing rheumatoid arthritis using an anti-IL-6 antibody Grant 11,180,549 - Chen , et al. November 23, 2	2021-11-23
Methods of Suppressing Rheumatoid Arthritis Using an Anti-IL-6 Antibody App 20200115445 - Chen; Yan ; et al.	2020-04-16
Methods of Suppressing Rheumatoid Arthritis Using An Anti-IL-6 Antibody App 20170253651 - Chen; Yan ; et al.	2017-09-07
Pen-injector device containing anti-IL-6 antibodies Grant 9,631,016 - Chen , et al. April 25, 2	2017-04-25
Toll-like receptor 3 antagonists Grant 9,481,731 - Cunningham , et al. November 1, 2	2016-11-01
Anti-IL-6 Antibodies, Compositions, Methods and Uses App 20160222104 - Chen; Yan ; et al.	2016-08-04
Anti-IL-6 antibodies, compositions, methods and uses Grant 9,340,613 - Chen , et al. May 17, 2	2016-05-17
Toll-Like Receptor 3 Antagonists App 20140212426 - Cunningham; Mark ; et al.	2014-07-31
Anti-IL-6 Antibodies, Compositions, Methods and Uses App 20140099311 - Chen; Yan ; et al.	2014-04-10
Toll-Like Receptor 3 Antagonists for the Treatment of Metabolic and Cardiovascular Diseases App 20140017250 - Cunningham; Mark ; et al.	2014-01-16
Anti-IL-6 antibodies Grant 8,623,362 - Chen , et al. January 7, 2	2014-01-07
Toll-like receptor 3 antagonists for the treatment of metabolic and cardiovascular diseases Grant 8,460,659 - Cunningham , et al. June 11, 2	2013-06-11
Toll-Like Receptor 3 Antagonists for the Treatment of Metabolic and Cardiovascular Diseases App 20130090457 - Cunningham; Mark ; et al.	2013-04-11
Anti-IL-6 Antibodies, Compositions, Methods and Uses App 20130017208 - Chen; Yan ; et al.	2013-01-17
Anti-IL-6 antibodies, compositions, methods and uses Grant RE43,672 - Chan , et al. September 18, 2	2012-09-18
Implantable pump for protein delivery for obesity control by drug infusion into the brain Grant 8,252,744 - Stojanovic-Susulic , et al. August 28, 2	2012-08-28
Toll Like Receptor 3 Antagonists, Methods and Uses App 20120189643 - Carton; Jill M. ; et al.	2012-07-26
Anti-IL-6 antibodies, compositions, methods and uses Grant 8,226,611 - Chen , et al. July 24, 2	2012-07-24
Toll like receptor 3 antagonists, methods and uses Grant 8,153,583 - Carton , et al. April 10, 2	2012-04-10
Toll-like Receptor 3 Antagonists For The Treatment Of Metabolic And Cardiovascular Diseases App 20120064095 - Cunningham; Mark ; et al.	2012-03-15
Anti-IL-6 Antibodies, Compositions, Methods and Uses App 20120045453 - CHEN; YAN ; et al.	2012-02-23
Methods of treating conditions using anti-IL-6 antibodies Grant 8,067,003 - Chen , et al. November 29, 2	2011-11-29
Methods of Diagnosing and Treating Conditions Using Anti-IL-6 Antibodies App 20110081355 - CHEN; YAN ; et al.	2011-04-07
Melanocortin receptor binding mimetibodies, compositions, methods and uses Grant 7,910,101 - Cunningham , et al. March 22, 2	2011-03-22
Anti-IL-6 antibody nucleic acid molecules and methods Grant 7,833,755 - Chen , et al. November 16, 2	2010-11-16
Method for treating insulin sensitivity by long-acting GLP-1 receptor mimetibody agonists Grant 7,833,531 - O'Neil , et al. November 16, 2	2010-11-16
Implantable pump for protein delivery for obesity control by drug infusion into the brain Grant 7,790,671 - Stojanovic-Susulic , et al. September 7, 2	2010-09-07
Implantable Pump For Protein Delivery For Obesity Control By Drug Infusion Into The Brain App 20100183700 - Stojanovic-Susulic; Vedrana ; et al.	2010-07-22
Anti-IL-6 Antibody Nucleic Acid Molecules and Methods App 20090239258 - Chen; Yan ; et al.	2009-09-24
Melanocortin Receptor Binding Mimetibodies, Compositions, Methods and Uses App 20090186020 - Cunningham; Mark ; et al.	2009-07-23
Anti-il-6 antibodies, compositions, methods and uses Grant 7,560,112 - Chen , et al. July 14, 2	2009-07-14
Use of Toll-Like Receptor 4 Antagonists for the Treatment or Prevention of Osteoarthritic Conditions App 20090136509 - Blake; Simon ; et al.	2009-05-28
Use Of Long-acting Glp-1 Receptor Agonists To Improve Insulin Sensitivity And Lipid Profiles App 20090098108 - O'Neil; Karyn T. ; et al.	2009-04-16
Novel PTH responsive gene App 20070298492 - Robinson; John Allen ; et al.	2007-12-27
PTH responsive gene Grant 7,258,999 - Robinson , et al. August 21, 2	2007-08-21
Implantable pump for protein delivery for obesity control by drug infusion into the brain App 20070082843 - Stojanovic-Susulic; Vedrana ; et al.	2007-04-12
Anti-IL-6 antibodies, compositions, methods and uses App 20060257407 - Chen; Yan ; et al.	2006-11-16
Toll like receptor 3 antagonists, methods and uses App 20060115475 - Carton; Jill M. ; et al.	2006-06-01
Melanocortin receptor binding mimetibodies, compositions, methods and uses App 20060105951 - Cunningham; Mark ; et al.	2006-05-18
Novel PTH responsive gene App 20040146906 - Robinson, John Allen ; et al.	2004-07-29

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.